MIRO | Miromatrix Medical Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.36 - 3.53
52 Week Range	0.9060 - 4.35
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	631,561
Average Volume	163,022
Shares Outstanding	27,419,200
Market Cap	92,951,088
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-06-24

Valuation
Profitability
Growth
Health
P/E Ratio	-2.97
Forward P/E Ratio	N/A
EPS	-1.14
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	76
Country	USA
Website	MIRO

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

MIRO's peers: ATHE, AVTX, BCDA, BNOX, CING, GTBP, IKT, LVTX, MBRX, MRKR, MTEM, NLSP, ONCT, PCSA, PPBT, PSTV, RANI, SYBX, TARA, VCNX, VINC, LIPO, CVKD

*Chart delayed

Analyzing fundamentals for MIRO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is very weak. For more detailed analysis please see MIRO Fundamentals page.

Watching at MIRO technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on MIRO Technicals page.